Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001420773 | SCV001623124 | likely benign | not specified | 2021-05-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002554097 | SCV003481339 | likely benign | Noonan syndrome 9 | 2023-10-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004681170 | SCV005170315 | likely benign | Cardiovascular phenotype | 2024-03-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |